NEW YORK (GenomeWeb News) – A bill to create a national institute to study comparative clinical effectiveness of medical treatments and diagnostics — including the use of molecular medicine and genetics to inform those studies — was introduced in the US Senate this week by Senators Max Baucus (D – Mont.) and Kent Conrad (D – ND).

The bill calls for the creation of the Patient-Centered Outcomes Research Institute, which would be a non-profit entity run by "a multi-stakeholder, public-private sector board of governors," Baucus said in a floor statement to the Senate on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.